Diagnostic Rating Tools
Tools for diagnosing PMDD can be challenging, but there are several diagnostic rating tools available. These tools typically require daily tracking for at least two menstrual cycles. One such tool is the Daily Record of Severity of Problems (DRSP), which uses summary scores to measure the severity and correlation of a woman’s symptoms. Another tool, the Calendar of Premenstrual Experiences (COPE), helps monitor and conceptualize behavioral and physical fluctuations during the menstrual period. By utilizing these forms, doctors can gain a better understanding of the extent of psychological and behavioral symptoms experienced by the patient.
Role of GABA and Serotonin
Exploring the Impact of GABA and Serotonin on PMDD
Scientists have put forth a hypothesis suggesting that women who experience Premenstrual Dysphoric Disorder (PMDD) may be more susceptible to certain neurotransmitters in the central nervous system. Specifically, they believe that serotonin and gamma-aminobutyric acid (GABA) play crucial roles during the latter half of a woman’s menstrual cycle, known as the luteal phase. While serotonin is responsible for generating positive emotions, GABA is recognized for its ability to induce relaxation.
According to research, it is believed that during the luteal phase, the effects of these two chemicals are somehow disrupted by ovarian steroids like estrogen. This disruption is considered to be a contributing factor to the development of PMDD. By better understanding the mechanisms behind the influence of GABA and serotonin on ovarian function, scientists hope to shed more light on this complex disorder.